These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23207485)

  • 21. Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.
    Hoffmann T; Meyer A; Heiser U; Kurat S; Böhme L; Kleinschmidt M; Bühring KU; Hutter-Paier B; Farcher M; Demuth HU; Lues I; Schilling S
    J Pharmacol Exp Ther; 2017 Jul; 362(1):119-130. PubMed ID: 28446518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet beta-secretase activity is increased in Alzheimer's disease.
    Johnston JA; Liu WW; Coulson DT; Todd S; Murphy S; Brennan S; Foy CJ; Craig D; Irvine GB; Passmore AP
    Neurobiol Aging; 2008 May; 29(5):661-8. PubMed ID: 17174011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can small molecule inhibitors of glutaminyl cyclase be used as a therapeutic for Alzheimer's disease?
    Wu H
    Future Med Chem; 2017 Nov; 9(17):1979-1981. PubMed ID: 29076753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease.
    Zhang W; Wang LZ; Yu JT; Chi ZF; Tan L
    J Neurol Sci; 2012 Apr; 315(1-2):67-71. PubMed ID: 22166855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet tau pattern correlates with cognitive status in Alzheimer's disease.
    Farías G; Pérez P; Slachevsky A; Maccioni RB
    J Alzheimers Dis; 2012; 31(1):65-9. PubMed ID: 22495344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A gene expression pattern in blood for the early detection of Alzheimer's disease.
    Booij BB; Lindahl T; Wetterberg P; Skaane NV; Sæbø S; Feten G; Rye PD; Kristiansen LI; Hagen N; Jensen M; Bårdsen K; Winblad B; Sharma P; Lönneborg A
    J Alzheimers Dis; 2011; 23(1):109-19. PubMed ID: 20930264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the value of plasma BIN1 as a potential biomarker for alzheimer's disease.
    Sun L; Tan MS; Hu N; Yu JT; Tan L
    J Alzheimers Dis; 2013; 37(2):291-5. PubMed ID: 23803295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
    Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
    Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R
    J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
    Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
    Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
    Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
    Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease.
    Smith ER; Nilforooshan R; Weaving G; Tabet N
    J Alzheimers Dis; 2011; 24(2):327-33. PubMed ID: 21239851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
    Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
    Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.
    Santos AN; Ewers M; Minthon L; Simm A; Silber RE; Blennow K; Prvulovic D; Hansson O; Hampel H
    J Alzheimers Dis; 2012; 29(1):171-6. PubMed ID: 22214781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.